Please use this identifier to cite or link to this item:
Title: The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective
Authors: Ansari, S
Hays, JP
Kemp, A
Okechukwu, R
Murugaiyan, J
Ekwanzala, MD
Ruiz Alvarez, MJ
Paul-Satyaseela, M
Iwu, CD
Balleste-Delpierre, C
Septimus, E
Mugisha, L
Fadare, J
Chaudhuri, S
Chibabhai, V
Wadanamby, JMRWW
Daoud, Z
Xiao, Y
Parkunan, T
Khalaf, Y
M'Ikanatha, NM
Van Dongen, MBM
Global AMR Insights Ambassador Network
Barkema, HW
Strathdee, S
Benyeogor, E
Ighodalo, UL
Prasad, KP
Carlos, M
Gu, Y
Essack, S
De Silva, D
Vellinga, A
Mommtaz Ghannam, W
Tsoho, NA
Sakeena, MHF
Ilenwabor, R
Shetty, D
Ayebare, A
Traore, ZI
Henry, O
Kiran, A
Ilanwabor, R
Toro, LF
Smail, A
Amulele, A
Founou, LL
Sawant, PS
Buregyeya, E
Castro-Sánchez, E
Moreno-Morales, J
Izadjoo, M
Gori, A
Goff, D
Blocker, A
Forte, G
Tahir, MF
Diggle, M
Chakraborty, D
Asamoah, AE
Aberi, H
Keywords: antibiotics;coronavirus;critical illness;drug resistance;microbial;vaccination;world health;infections;diagnosis;pathogenic organism;antimicrobials;biocides;antimicrobial stewardships;ars-cov-2;covid-19;coronavirus pandemic
Issue Date: 8-Apr-2021
Publisher: Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy
Citation: Ansari, S. et al on behalf of Global AMR Insights Ambassador Network (2021) 'The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective', JAC-Antimicrobial Resistance, 3 (2), dlab038, pp. 1 - 12. doi: 10.1093/jacamr/dlab038.
Abstract: Copyright © The Author(s) 2021. The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic’s potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic’s effect on global AMR.
Other Identifiers: ORCID iDs: Shamshul Ansari; Maneesh Paul-Satyaseela; Joseph Fadare; Yara Khalaf; Nkuchia M M’Ikanatha; Enrique Castro-Sánchez
Appears in Collections:Dept of Arts and Humanities Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (, which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com759.68 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons